Rapamycin (sirolimus) is a macrolide product of Streptomyces hygroscopicus that inhibits mammalian target of rapamycin (mTOR) making it an effective immunosuppressant for treatment of allograft rejection and several cancers [157,158]. Here, MTOR is linked to cancer.